EUROPEAN JOURNAL OF MEDICAL RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2261515, encodeId=4cb022615159a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝损伤 经验分享：请问投稿快一个月了，一直停在Editor assigned状态，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d576497865, createdName=ms2000000271791251, createdTime=Tue Apr 22 08:40:10 CST 2025, time=2025-04-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248405, encodeId=22752248405f5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经病学 经验分享：Congratulations! Your submission has been accepted for publication。在哪里缴费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c839101585, createdName=ms9000000012593530, createdTime=Fri Jan 17 02:25:08 CST 2025, time=2025-01-17, status=1, ipAttribution=马德里), GetPortalCommentsPageByObjectIdResponse(id=2257157, encodeId=5f6a225e157e6, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;内分泌 经验分享：一审就拉十几个审稿人出来了，然后一直不返意见回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b19647585, createdName=ms7000000525047375, createdTime=Fri Mar 21 18:51:49 CST 2025, time=2025-03-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2255478, encodeId=80d922554e8fa, content=偏重的研究方向：糖尿病;临床 经验分享：返修过程里加了一个作者，编辑发来一个表格要求所有作者的签名同意加入该作者，请问这种情况会增加拒稿风险吗？有点嫌麻烦，想给编辑回消息说可以不加作者这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Mar 10 17:03:56 CST 2025, time=2025-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250759, encodeId=bbdd2250e5928, content=期刊表示不接受BIB文章，“Specifically, the journal does not consider bibliometric studies. ”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Feb 06 17:11:56 CST 2025, time=2025-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津)]

2024-01-12 ms9000000801374228 来自广东省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：临床
经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2261515, encodeId=4cb022615159a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝损伤 经验分享：请问投稿快一个月了，一直停在Editor assigned状态，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d576497865, createdName=ms2000000271791251, createdTime=Tue Apr 22 08:40:10 CST 2025, time=2025-04-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248405, encodeId=22752248405f5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经病学 经验分享：Congratulations! Your submission has been accepted for publication。在哪里缴费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c839101585, createdName=ms9000000012593530, createdTime=Fri Jan 17 02:25:08 CST 2025, time=2025-01-17, status=1, ipAttribution=马德里), GetPortalCommentsPageByObjectIdResponse(id=2257157, encodeId=5f6a225e157e6, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;内分泌 经验分享：一审就拉十几个审稿人出来了，然后一直不返意见回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b19647585, createdName=ms7000000525047375, createdTime=Fri Mar 21 18:51:49 CST 2025, time=2025-03-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2255478, encodeId=80d922554e8fa, content=偏重的研究方向：糖尿病;临床 经验分享：返修过程里加了一个作者，编辑发来一个表格要求所有作者的签名同意加入该作者，请问这种情况会增加拒稿风险吗？有点嫌麻烦，想给编辑回消息说可以不加作者这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Mar 10 17:03:56 CST 2025, time=2025-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250759, encodeId=bbdd2250e5928, content=期刊表示不接受BIB文章，“Specifically, the journal does not consider bibliometric studies. ”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Feb 06 17:11:56 CST 2025, time=2025-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津)]

2025-04-22 ms2000000271791251 来自安徽省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肝损伤
经验分享：请问投稿快一个月了，一直停在Editor assigned状态，这是什么情况？

4 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2261515, encodeId=4cb022615159a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝损伤 经验分享：请问投稿快一个月了，一直停在Editor assigned状态，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d576497865, createdName=ms2000000271791251, createdTime=Tue Apr 22 08:40:10 CST 2025, time=2025-04-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248405, encodeId=22752248405f5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经病学 经验分享：Congratulations! Your submission has been accepted for publication。在哪里缴费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c839101585, createdName=ms9000000012593530, createdTime=Fri Jan 17 02:25:08 CST 2025, time=2025-01-17, status=1, ipAttribution=马德里), GetPortalCommentsPageByObjectIdResponse(id=2257157, encodeId=5f6a225e157e6, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;内分泌 经验分享：一审就拉十几个审稿人出来了，然后一直不返意见回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b19647585, createdName=ms7000000525047375, createdTime=Fri Mar 21 18:51:49 CST 2025, time=2025-03-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2255478, encodeId=80d922554e8fa, content=偏重的研究方向：糖尿病;临床 经验分享：返修过程里加了一个作者，编辑发来一个表格要求所有作者的签名同意加入该作者，请问这种情况会增加拒稿风险吗？有点嫌麻烦，想给编辑回消息说可以不加作者这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Mar 10 17:03:56 CST 2025, time=2025-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250759, encodeId=bbdd2250e5928, content=期刊表示不接受BIB文章，“Specifically, the journal does not consider bibliometric studies. ”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Feb 06 17:11:56 CST 2025, time=2025-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津)]

2025-01-17 ms9000000012593530 来自马德里

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：神经病学
经验分享：Congratulations! Your submission has been accepted for publication。在哪里缴费啊？

16 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2261515, encodeId=4cb022615159a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝损伤 经验分享：请问投稿快一个月了，一直停在Editor assigned状态，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d576497865, createdName=ms2000000271791251, createdTime=Tue Apr 22 08:40:10 CST 2025, time=2025-04-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248405, encodeId=22752248405f5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经病学 经验分享：Congratulations! Your submission has been accepted for publication。在哪里缴费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c839101585, createdName=ms9000000012593530, createdTime=Fri Jan 17 02:25:08 CST 2025, time=2025-01-17, status=1, ipAttribution=马德里), GetPortalCommentsPageByObjectIdResponse(id=2257157, encodeId=5f6a225e157e6, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;内分泌 经验分享：一审就拉十几个审稿人出来了，然后一直不返意见回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b19647585, createdName=ms7000000525047375, createdTime=Fri Mar 21 18:51:49 CST 2025, time=2025-03-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2255478, encodeId=80d922554e8fa, content=偏重的研究方向：糖尿病;临床 经验分享：返修过程里加了一个作者，编辑发来一个表格要求所有作者的签名同意加入该作者，请问这种情况会增加拒稿风险吗？有点嫌麻烦，想给编辑回消息说可以不加作者这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Mar 10 17:03:56 CST 2025, time=2025-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250759, encodeId=bbdd2250e5928, content=期刊表示不接受BIB文章，“Specifically, the journal does not consider bibliometric studies. ”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Feb 06 17:11:56 CST 2025, time=2025-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津)]

2025-03-21 ms7000000525047375 来自湖南省

审稿速度:12.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤;内分泌
经验分享：一审就拉十几个审稿人出来了，然后一直不返意见回来

9 0

[GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2261515, encodeId=4cb022615159a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝损伤 经验分享：请问投稿快一个月了，一直停在Editor assigned状态，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d576497865, createdName=ms2000000271791251, createdTime=Tue Apr 22 08:40:10 CST 2025, time=2025-04-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248405, encodeId=22752248405f5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经病学 经验分享：Congratulations! Your submission has been accepted for publication。在哪里缴费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c839101585, createdName=ms9000000012593530, createdTime=Fri Jan 17 02:25:08 CST 2025, time=2025-01-17, status=1, ipAttribution=马德里), GetPortalCommentsPageByObjectIdResponse(id=2257157, encodeId=5f6a225e157e6, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;内分泌 经验分享：一审就拉十几个审稿人出来了，然后一直不返意见回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b19647585, createdName=ms7000000525047375, createdTime=Fri Mar 21 18:51:49 CST 2025, time=2025-03-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2255478, encodeId=80d922554e8fa, content=偏重的研究方向：糖尿病;临床 经验分享：返修过程里加了一个作者，编辑发来一个表格要求所有作者的签名同意加入该作者，请问这种情况会增加拒稿风险吗？有点嫌麻烦，想给编辑回消息说可以不加作者这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Mar 10 17:03:56 CST 2025, time=2025-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250759, encodeId=bbdd2250e5928, content=期刊表示不接受BIB文章，“Specifically, the journal does not consider bibliometric studies. ”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Feb 06 17:11:56 CST 2025, time=2025-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津)]

2025-03-10 ms6000000357694689 来自北京

偏重的研究方向：糖尿病;临床
经验分享：返修过程里加了一个作者，编辑发来一个表格要求所有作者的签名同意加入该作者，请问这种情况会增加拒稿风险吗？有点嫌麻烦，想给编辑回消息说可以不加作者这样可以吗

14 0

[GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2261515, encodeId=4cb022615159a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝损伤 经验分享：请问投稿快一个月了，一直停在Editor assigned状态，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d576497865, createdName=ms2000000271791251, createdTime=Tue Apr 22 08:40:10 CST 2025, time=2025-04-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248405, encodeId=22752248405f5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经病学 经验分享：Congratulations! Your submission has been accepted for publication。在哪里缴费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c839101585, createdName=ms9000000012593530, createdTime=Fri Jan 17 02:25:08 CST 2025, time=2025-01-17, status=1, ipAttribution=马德里), GetPortalCommentsPageByObjectIdResponse(id=2257157, encodeId=5f6a225e157e6, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;内分泌 经验分享：一审就拉十几个审稿人出来了，然后一直不返意见回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b19647585, createdName=ms7000000525047375, createdTime=Fri Mar 21 18:51:49 CST 2025, time=2025-03-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2255478, encodeId=80d922554e8fa, content=偏重的研究方向：糖尿病;临床 经验分享：返修过程里加了一个作者，编辑发来一个表格要求所有作者的签名同意加入该作者，请问这种情况会增加拒稿风险吗？有点嫌麻烦，想给编辑回消息说可以不加作者这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Mar 10 17:03:56 CST 2025, time=2025-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250759, encodeId=bbdd2250e5928, content=期刊表示不接受BIB文章，“Specifically, the journal does not consider bibliometric studies. ”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Feb 06 17:11:56 CST 2025, time=2025-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津)]

2024-11-07 匿名用户

2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization.

49 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2261515, encodeId=4cb022615159a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝损伤 经验分享：请问投稿快一个月了，一直停在Editor assigned状态，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d576497865, createdName=ms2000000271791251, createdTime=Tue Apr 22 08:40:10 CST 2025, time=2025-04-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248405, encodeId=22752248405f5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经病学 经验分享：Congratulations! Your submission has been accepted for publication。在哪里缴费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c839101585, createdName=ms9000000012593530, createdTime=Fri Jan 17 02:25:08 CST 2025, time=2025-01-17, status=1, ipAttribution=马德里), GetPortalCommentsPageByObjectIdResponse(id=2257157, encodeId=5f6a225e157e6, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;内分泌 经验分享：一审就拉十几个审稿人出来了，然后一直不返意见回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b19647585, createdName=ms7000000525047375, createdTime=Fri Mar 21 18:51:49 CST 2025, time=2025-03-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2255478, encodeId=80d922554e8fa, content=偏重的研究方向：糖尿病;临床 经验分享：返修过程里加了一个作者，编辑发来一个表格要求所有作者的签名同意加入该作者，请问这种情况会增加拒稿风险吗？有点嫌麻烦，想给编辑回消息说可以不加作者这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Mar 10 17:03:56 CST 2025, time=2025-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250759, encodeId=bbdd2250e5928, content=期刊表示不接受BIB文章，“Specifically, the journal does not consider bibliometric studies. ”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Feb 06 17:11:56 CST 2025, time=2025-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津)]

2025-02-06 匿名用户

期刊表示不接受BIB文章，“Specifically, the journal does not consider bibliometric studies. ”

11 0

[GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2261515, encodeId=4cb022615159a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝损伤 经验分享：请问投稿快一个月了，一直停在Editor assigned状态，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d576497865, createdName=ms2000000271791251, createdTime=Tue Apr 22 08:40:10 CST 2025, time=2025-04-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248405, encodeId=22752248405f5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经病学 经验分享：Congratulations! Your submission has been accepted for publication。在哪里缴费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c839101585, createdName=ms9000000012593530, createdTime=Fri Jan 17 02:25:08 CST 2025, time=2025-01-17, status=1, ipAttribution=马德里), GetPortalCommentsPageByObjectIdResponse(id=2257157, encodeId=5f6a225e157e6, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;内分泌 经验分享：一审就拉十几个审稿人出来了，然后一直不返意见回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b19647585, createdName=ms7000000525047375, createdTime=Fri Mar 21 18:51:49 CST 2025, time=2025-03-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2255478, encodeId=80d922554e8fa, content=偏重的研究方向：糖尿病;临床 经验分享：返修过程里加了一个作者，编辑发来一个表格要求所有作者的签名同意加入该作者，请问这种情况会增加拒稿风险吗？有点嫌麻烦，想给编辑回消息说可以不加作者这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Mar 10 17:03:56 CST 2025, time=2025-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250759, encodeId=bbdd2250e5928, content=期刊表示不接受BIB文章，“Specifically, the journal does not consider bibliometric studies. ”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Feb 06 17:11:56 CST 2025, time=2025-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津)]

2024-06-05 ms1000000972447414 来自新疆

请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？

86 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2261515, encodeId=4cb022615159a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝损伤 经验分享：请问投稿快一个月了，一直停在Editor assigned状态，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d576497865, createdName=ms2000000271791251, createdTime=Tue Apr 22 08:40:10 CST 2025, time=2025-04-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248405, encodeId=22752248405f5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经病学 经验分享：Congratulations! Your submission has been accepted for publication。在哪里缴费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c839101585, createdName=ms9000000012593530, createdTime=Fri Jan 17 02:25:08 CST 2025, time=2025-01-17, status=1, ipAttribution=马德里), GetPortalCommentsPageByObjectIdResponse(id=2257157, encodeId=5f6a225e157e6, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;内分泌 经验分享：一审就拉十几个审稿人出来了，然后一直不返意见回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b19647585, createdName=ms7000000525047375, createdTime=Fri Mar 21 18:51:49 CST 2025, time=2025-03-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2255478, encodeId=80d922554e8fa, content=偏重的研究方向：糖尿病;临床 经验分享：返修过程里加了一个作者，编辑发来一个表格要求所有作者的签名同意加入该作者，请问这种情况会增加拒稿风险吗？有点嫌麻烦，想给编辑回消息说可以不加作者这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Mar 10 17:03:56 CST 2025, time=2025-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250759, encodeId=bbdd2250e5928, content=期刊表示不接受BIB文章，“Specifically, the journal does not consider bibliometric studies. ”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Feb 06 17:11:56 CST 2025, time=2025-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津)]

2024-09-25 ms7000000417591078 来自天津

审稿速度:12.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤
经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷

41 0

[GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2261515, encodeId=4cb022615159a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肝损伤 经验分享：请问投稿快一个月了，一直停在Editor assigned状态，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d576497865, createdName=ms2000000271791251, createdTime=Tue Apr 22 08:40:10 CST 2025, time=2025-04-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2248405, encodeId=22752248405f5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经病学 经验分享：Congratulations! Your submission has been accepted for publication。在哪里缴费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c839101585, createdName=ms9000000012593530, createdTime=Fri Jan 17 02:25:08 CST 2025, time=2025-01-17, status=1, ipAttribution=马德里), GetPortalCommentsPageByObjectIdResponse(id=2257157, encodeId=5f6a225e157e6, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;内分泌 经验分享：一审就拉十几个审稿人出来了，然后一直不返意见回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b19647585, createdName=ms7000000525047375, createdTime=Fri Mar 21 18:51:49 CST 2025, time=2025-03-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2255478, encodeId=80d922554e8fa, content=偏重的研究方向：糖尿病;临床 经验分享：返修过程里加了一个作者，编辑发来一个表格要求所有作者的签名同意加入该作者，请问这种情况会增加拒稿风险吗？有点嫌麻烦，想给编辑回消息说可以不加作者这样可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Mar 10 17:03:56 CST 2025, time=2025-03-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250759, encodeId=bbdd2250e5928, content=期刊表示不接受BIB文章，“Specifically, the journal does not consider bibliometric studies. ”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Feb 06 17:11:56 CST 2025, time=2025-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津)]

2024-08-18 ms7000000417591078 来自天津

被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了

123 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务